– UK, London – RSA Insurance Group plc (LSE:RSA), today announces the appointment of Martin Strobel as a Non-Executive Board Director as of 1st May 2016. He will also join the Audit, Investment and Remuneration Committees.
Martin has over 23 years insurance and financial services experience, most recently as Chief Executive Officer of Baloise Group, a position he held for seven years to 2015. He joined Baloise Group in 1999 as the Head of IT at Basler Switzerland and, within Baloise Group, was responsible for major cross-functional insurance and finance projects. From 2003 to 2008 he was a member of the Corporate Executive Committee with responsibility for the Corporate Division Switzerland. From 1993 to 1999 Martin performed various roles at Boston Consulting Group, Düsseldorf, advising businesses in the banking and the insurance sectors.
Commenting on the appointment, RSA Chairman Martin Scicluna said: “We are delighted to welcome Martin to RSA’s Board. He brings a deep understanding of the insurance sector and a wealth of financial services expertise, particularly in driving successful transformation programmes across international businesses. We look forward to leveraging his direct industry experience and knowledge to ensure that RSA continues to deliver value for its customers and shareholders while advancing its operational priorities.”
About RSA:
With a 300 year heritage, RSA is one of the world’s leading multinational quoted insurance groups. Focusing on general insurance, RSA’s core markets are the UK and Ireland, Scandinavia and Canada with the capability to write business across the globe. We have around 14,000 employees across the core businesses and, in 2015, our net written premiums were £6.8 billion.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
